Promoting Immune Efficacy of the Oral <i>Helicobacter pylori</i> Vaccine by HP55/PBCA Nanoparticles against the Gastrointestinal Environment
Hai Liu(China Pharmaceutical University), Yingying Xing(China Pharmaceutical University), Linlin Wang(Qingdao University), Wei Liu(Second People’s Hospital of Yibin), Huimin Yang(China Pharmaceutical University), Shuanghui Luo(China Pharmaceutical University), Zhoulin Tan(China Pharmaceutical University), Zhiqin Zeng(China Pharmaceutical University), Tao Xi(China Pharmaceutical University)
Cited by 18
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609